ACOG 2024 recap: contraception, COVID-19 vaccination, and more
Review some of the top stories from Contemporary OB/GYN's coverage of ACOG 2024, and catch up on anything you may have missed.
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from ACOG 2024, and click each link to read and watch anything you may have missed.
1.) Meeting the contraceptive needs of transgender and gender nonbinary individuals
A symposium at ACOG 2024 focused on how to boost clinician confidence when it comes to contraception education for this patient population.
Click here for the full video.
2.) COVID-19 vaccination and its impact on menstrual cycles
Alison Edelman, MD, MPH, dives into her research presented at the 2024 ACOG Annual Clinical and Scientific Meeting on COVID-19 vaccination and it's impact on the menstrual cycle.
Click here for the full video.
3.) Buprenorphine use in pregnancy linked to decreased fetal breathing movements
According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Click here for the full article.
4.) Survey: State abortion access impacted OB/GYN residency applications
National survey data presented at ACOG 2024 shows many medical students applying for OB/GYN residencies prioritized states with abortion access.
Click here for the full article.
5.) New data shows elinzanetant's efficacy in treating menopausal symptoms
Phase 3 data presented by JoAnn Pinkerton, MD, reveals that elinzanetant significantly improves hot flash frequency, sleep, and overall menopause quality of life, offering a promising alternative to estrogen therapy.
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
